{"gene":"C1GALT1C1","run_date":"2026-06-09T22:02:45","timeline":{"discoveries":[{"year":2002,"finding":"Cosmc (C1GALT1C1) is a specific molecular chaperone required for the activity of core 1 β3-galactosyltransferase (T-synthase/C1beta3Gal-T). Without Cosmc, T-synthase is targeted to proteasomes and degraded. A small portion of T-synthase co-purifies with Cosmc from cell extracts, demonstrating direct physical association. Expression of Cosmc cDNA in Jurkat cells (which carry a mutated Cosmc with a premature stop codon) restored T-synthase activity and T antigen expression.","method":"Co-purification from cell extracts, cDNA rescue in Cosmc-mutant Jurkat cells, co-expression in insect cells, proteasome inhibitor studies","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — multiple orthogonal methods (co-purification, genetic rescue, insect cell reconstitution), foundational paper replicated by subsequent studies","pmids":["12464682"],"is_preprint":false},{"year":2002,"finding":"C1Gal-T2 (an alias for C1GALT1C1 as used in this paper, but note: this paper describes a paralog C1Gal-T2 with 26% homology to C1Gal-T1 that also has core 1 synthase activity). LSC and Jurkat cells lacking core 1 synthase activity were found to have null alleles of C1Gal-T2, indicating C1Gal-T2 contributes to core 1 O-glycan synthesis.","method":"Stable transfection of LSC cells, microsome enzyme activity assay, flow cytometry, lectin blotting, allele sequencing","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — enzyme activity assay in transfected cells plus allele analysis, single lab; note this paper describes the C1Gal-T2 paralog/isoform with independent catalytic activity","pmids":["12361956"],"is_preprint":false},{"year":2008,"finding":"Cosmc is an endoplasmic reticulum (ER)-localized, ATP-binding molecular chaperone that directly binds to human T-synthase, prevents its aggregation, and blocks ubiquitin-mediated degradation of T-synthase.","method":"Subcellular fractionation and immunolocalization, ATP-binding assays, ubiquitination assays, direct binding experiments","journal":"The Journal of cell biology","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — direct binding demonstrated, ER localization established by fractionation, ubiquitin-mediated degradation pathway defined with multiple methods","pmids":["18695044"],"is_preprint":false},{"year":2008,"finding":"Somatic loss-of-function mutations in Cosmc cause expression of tumor-associated Tn and sialyl-Tn (STn) antigens in diverse neoplastic cell lines (colon cancer, melanoma) and human cervical cancer specimens, accompanied by loss of heterozygosity at the X-linked Cosmc locus.","method":"Sequencing of Cosmc gene in cancer cell lines and tumor specimens, LOH analysis, correlation with antigen expression by immunostaining","journal":"Cancer research","confidence":"High","confidence_rationale":"Tier 2 / Strong — direct sequencing of mutations correlated with antigen expression across multiple cancer types and specimens, replicated in multiple cell lines","pmids":["18339842"],"is_preprint":false},{"year":2009,"finding":"The lumenal domain of recombinant Cosmc directly interacts specifically with denatured (non-native) T-synthase in vitro, forming a stable complex and promoting partial refolding and restoration of T-synthase activity in an ATP-independent manner. A Tn-syndrome-associated mutant Cosmc has reduced chaperone function. The reactivated T-synthase remains noncovalently bound to Cosmc, and dissociation is promoted by client-driven competition with additional non-native T-synthase.","method":"In vitro refolding assay with recombinant proteins, solid-support binding assay, enzyme activity measurement, mutant Cosmc comparison","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Strong — in vitro reconstitution with recombinant proteins, mutagenesis of disease-associated variant, multiple orthogonal assays","pmids":["19923218"],"is_preprint":false},{"year":2010,"finding":"Ablation of the X-linked Cosmc gene in mice causes embryonic lethality and widespread Tn antigen expression. Loss of Cosmc is specifically associated with loss of T-synthase protein but not other glycosylation enzymes, demonstrating that Cosmc is specifically required for T-synthase in vivo. Genetically mosaic mice with Cosmc deletion showed abnormalities correlated with Tn antigen expression.","method":"Conditional/germline gene knockout in mice, immunostaining for Tn antigen, enzyme activity assays, Western blot for glycosylation enzymes","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic ablation in mice with specific molecular phenotype, demonstrates in vivo specificity for T-synthase among glycosylation enzymes","pmids":["20439703"],"is_preprint":false},{"year":2011,"finding":"The 18-amino acid transmembrane domain (TMD) of Cosmc is essential for ER localization and confers ER retention to chimeric proteins. A single Cys residue within the TMD is required for disulfide-bonded dimerization of Cosmc and ER retention; mutation of this Cys prevents dimer formation and eliminates ER retention.","method":"Chimeric protein construction with transferrin receptor, site-directed mutagenesis of Cys in TMD, immunofluorescence localization, biochemical analysis of dimer formation","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1–2 / Moderate — mutagenesis combined with chimeric protein approach and localization, identifies specific ER-retention motif within TMD","pmids":["21262965"],"is_preprint":false},{"year":2011,"finding":"Cosmc mediates co-translational activation of C1GalT (T-synthase). Recombinant Cosmc must be present during translation of C1GalT to be effective; addition of Cosmc after translation does not restore activity, indicating Cosmc acts co-translationally to prevent unfavorable aggregation.","method":"Wheat germ cell-free translation system, simultaneous vs. post-translational addition of recombinant Cosmc, enzyme activity assay","journal":"FEBS letters","confidence":"Medium","confidence_rationale":"Tier 1 / Weak — cell-free translation reconstitution is Tier 1 but single lab, single study","pmids":["21496458"],"is_preprint":false},{"year":2012,"finding":"Cosmc binds specifically to denatured (non-native) T-synthase but not to the active dimeric form. Dissociation of T-synthase from the Cosmc complex is promoted by client-driven interaction with additional free non-native or native T-synthase molecules, defining a novel client-driven chaperone cycle.","method":"In vitro binding assays with recombinant lumenal domain of Cosmc on solid support, enzyme reactivation assays, competition experiments with free T-synthase forms","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Moderate — in vitro reconstitution with recombinant proteins, multiple conditions tested, defines mechanism of complex dissociation","pmids":["22416136"],"is_preprint":false},{"year":2012,"finding":"Epigenetic silencing of Cosmc through hypermethylation of its promoter CpG islands leads to loss of Cosmc transcripts in Tn4 B cells, resulting in absence of T-synthase activity and Tn antigen expression. Treatment with the demethylating agent 5-aza-2'-deoxycytidine restores Cosmc transcripts, T-synthase activity, and reduces Tn antigen expression.","method":"Bisulfite sequencing of Cosmc promoter, 5-aza-2'-deoxycytidine treatment, RT-PCR for Cosmc transcripts, T-synthase activity assay, flow cytometry for Tn antigen","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Moderate — bisulfite sequencing plus pharmacological rescue with two orthogonal readouts (transcript and enzyme activity), mechanistic link established","pmids":["23035125"],"is_preprint":false},{"year":2007,"finding":"Immunocytochemical analysis established that C1GalT (T-synthase) localizes to the Golgi apparatus while Cosmc localizes to the endoplasmic reticulum in human colon cancer cells. In Cosmc-mutant LSC cells, C1GalT protein is absent; proteasome inhibition with lactacystin causes accumulation of C1GalT but not in the Golgi. Overexpression of Cosmc directs C1GalT to the Golgi and restores core 1 synthase activity, demonstrating Cosmc controls the intracellular dynamics and proper Golgi targeting of C1GalT.","method":"Monoclonal antibody-based immunocytochemistry, proteasome inhibitor (lactacystin) treatment, Cosmc overexpression, co-localization with organelle markers","journal":"Biochemical and biophysical research communications","confidence":"High","confidence_rationale":"Tier 2 / Moderate — direct imaging with specific antibodies, functional rescue by overexpression, proteasome inhibitor validation, mechanistically defines chaperone-dependent Golgi trafficking","pmids":["18061573"],"is_preprint":false},{"year":2014,"finding":"A cryptic linear, relatively hydrophobic peptide in the N-terminal stem region of T-synthase (termed CBRT, Cosmc binding region within T-synthase) is essential for binding to Cosmc. A synthetic CBRT peptide directly interacts with Cosmc and inhibits Cosmc-assisted in vitro refolding of T-synthase. Mutations within CBRT diminish T-synthase binding to Cosmc and result in formation of inactive T-synthase. Insertion of the T-synthase stem region into β4GalT1 confers Cosmc binding onto this chimera.","method":"Deletion mutagenesis, synthetic peptide binding assay, in vitro refolding inhibition assay, domain swap chimeric protein experiment, T-synthase activity assay","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Moderate — multiple orthogonal methods including mutagenesis, synthetic peptide binding, and domain swap chimera in a single study","pmids":["24616093"],"is_preprint":false},{"year":2015,"finding":"The Cosmc core promoter, located within a CpG island (cCpG-II), contains two binding sites for Krüppel-like transcription factors (SP1/SP3), which drive basal ubiquitous transcription of Cosmc. Methylome analysis confirmed hypermethylation of the Cosmc core promoter in Tn4 B cells with silenced Cosmc, but not of the T-synthase promoter, demonstrating differential epigenetic regulation.","method":"Luciferase reporter assays, site-directed mutagenesis of SP1/SP3 binding sites, ChIP assays, mithramycin A treatment, methylome analysis/bisulfite sequencing","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1–2 / Moderate — multiple orthogonal methods (reporter assay, mutagenesis, ChIP, pharmacological inhibition) identify specific transcription factor binding sites","pmids":["26063800"],"is_preprint":false},{"year":2017,"finding":"Limited proteolysis reveals Cosmc has a structured N-terminal domain (CosmcΔ256) with wild-type chaperone activity. The C-terminal domain is required for oligomerization (Cosmc forms monomeric, dimeric, trimeric, and tetrameric species) and divalent cation binding. The N-terminal domain mediates T-synthase binding. The disease-associated CosmcE152K mutant shows wild-type-like activity in vitro despite loss of function in vivo.","method":"Limited proteolysis, chemical crosslinking, blue native PAGE electrophoresis, thermal shift assays for metal binding, in vitro chaperone activity assays with truncation and point mutants","journal":"PloS one","confidence":"High","confidence_rationale":"Tier 1–2 / Moderate — multiple biochemical methods characterize domain organization and oligomerization, mutagenesis separates functional domains","pmids":["28665962"],"is_preprint":false},{"year":2013,"finding":"Forced expression of Cosmc in HCT116 colon cancer cells increases T antigen expression and enhances cell growth, migration, and invasion via increased phosphorylation of FAK, ERK, and Akt. These effects are suppressed by MEK or PI3K inhibitors. Knockdown of Cosmc in SW480 cells decreases malignant behaviors and these signaling pathways, effects reversed by constitutively active Akt or MEK.","method":"Forced overexpression and siRNA knockdown, Western blot for phospho-FAK/ERK/Akt, MEK/PI3K inhibitors, cell growth/migration/invasion assays, in vivo SCID mouse tumor model","journal":"Molecular carcinogenesis","confidence":"Medium","confidence_rationale":"Tier 2–3 / Moderate — gain- and loss-of-function with pathway inhibitor rescue, in vivo validation, but mechanism linking O-glycosylation to kinase activation not directly established","pmids":["23390052"],"is_preprint":false},{"year":2013,"finding":"COSMC overexpression in HUVECs increases T antigen expression, enhances cell growth, and increases phosphorylation of AKT and ERK. VEGFR2 carries O-glycans modulated by COSMC; COSMC overexpression delays VEGFR2 degradation while COSMC knockdown facilitates it. COSMC regulates VEGF-triggered phosphorylation of VEGFR2.","method":"Overexpression and siRNA knockdown, Western blot for O-glycans on VEGFR2, VEGFR2 degradation assay, VEGF stimulation assay, cell growth assays","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 2–3 / Moderate — identifies VEGFR2 as an O-glycoprotein substrate of Cosmc-dependent glycosylation with functional consequences for receptor stability and signaling","pmids":["23424651"],"is_preprint":false},{"year":2016,"finding":"Deletion of Cosmc in mouse intestinal epithelial cells (IEC-Cosmc-KO) causes marked reduction of microbiota diversity progressing from proximal to distal gut mucosa (but not lumen), emergence of a proinflammatory pathobiont, and distal gut pathology. Cosmc regulates host genes, bacterial ligands, and nutrient availability to control microbiota biogeography. Loss of one Cosmc allele in males causes compromised mucus layer and spontaneous microbe-dependent inflammation; female mosaic heterozygotes are protected due to lateral migration of normal mucin glycocalyx from WT cells.","method":"Conditional intestinal epithelial cell-specific Cosmc knockout in mice, microbiome sequencing, histology, experimental colitis models, comparison of hemizygous males vs. heterozygous females","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 / Strong — conditional KO mouse model with defined cellular phenotype, microbiome analysis, multiple genetic configurations tested across sex","pmids":["27930307"],"is_preprint":false},{"year":2020,"finding":"B cell-specific deletion of Cosmc causes developmental blocks in mouse B cells and failure to home to lymph nodes and non-lymphoid organs after transfer. Enzymatic desialylation of WT B cells also blocks migration into lymph nodes, indicating sialylated O-glycans are required for trafficking. Cosmc-deficient B cells show normal rolling and firm arrest on high endothelium venules (HEV) but impaired transendothelial migration and defective chemokine signaling responses.","method":"B cell-specific conditional Cosmc KO, adoptive transfer experiments, enzymatic desialylation of WT B cells, intravital imaging for rolling/arrest on HEV, chemokine signaling assays","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 2 / Strong — conditional KO plus enzymatic rescue experiments, intravital imaging distinguishes rolling/arrest from transendothelial migration steps, multiple orthogonal approaches","pmids":["32778659"],"is_preprint":false},{"year":2020,"finding":"Podocyte-specific Cosmc knockout mice develop profound albuminuria, foot process effacement, glomerular sclerosis, progressive renal failure, and impaired survival. Podoplanin O-glycoprotein expression is lost, and Tn antigen is most abundantly found on podocalyxin in KO cells. Cosmc-deficient podocytes forming foot processes interdigitating with those of normal podocytes (but not other KO cells) maintain function, suggesting a cell non-autonomous mechanism for O-glycoproteins in podocyte function.","method":"Podocyte-specific conditional Cosmc knockout, albuminuria measurement, electron microscopy for foot processes, glomerular transcriptome analysis, immunostaining for O-glycoproteins, analysis of mosaic heterozygous females","journal":"American journal of physiology. Renal physiology","confidence":"High","confidence_rationale":"Tier 2 / Moderate — conditional KO with detailed molecular and ultrastructural phenotyping, mosaic female analysis reveals cell non-autonomous mechanism","pmids":["31904283"],"is_preprint":false},{"year":2019,"finding":"T cell-specific Cosmc conditional knockout (TCKO) mice show near-complete elimination of Cosmc-null T cells from spleen and lymph nodes. Cosmc-null thymocytes complete thymic maturation but fail to populate secondary lymphoid organs both natively and upon adoptive transfer to WT recipients, demonstrating that extended O-glycosylation is required for establishment and maintenance of the peripheral T cell population.","method":"Conditional T cell-specific Cosmc KO, flow cytometry for T cell populations, adoptive transfer experiments, thymocyte maturation analysis","journal":"Glycobiology","confidence":"High","confidence_rationale":"Tier 2 / Moderate — conditional KO with adoptive transfer dissects peripheral homing from thymic maturation, clean mechanistic separation","pmids":["31317176"],"is_preprint":false},{"year":2021,"finding":"B cell-specific deletion of Cosmc causes spontaneous autoimmunity with elevated self-reactive IgM and IgG autoantibodies, enhanced basal B cell activation, increased spontaneous germinal center B cells, and multiple pathological phenotypes. Mechanistically, loss of Cosmc-dependent core 1 O-glycans confers enhanced B cell receptor (BCR) signaling through diminished BCR internalization.","method":"B cell-conditional Cosmc KO mice, autoantibody profiling, BCR signaling assays, BCR internalization assays, germinal center analysis by flow cytometry","journal":"Science advances","confidence":"High","confidence_rationale":"Tier 2 / Moderate — conditional KO with defined mechanistic readout (BCR internalization) linking O-glycosylation to immune checkpoint function","pmids":["34613773"],"is_preprint":false},{"year":2023,"finding":"A germline hemizygous variant in C1GALT1C1 (c.59C>A, p.Ala20Asp) within the transmembrane domain of Cosmc results in dramatically reduced Cosmc protein expression (though the A20D-Cosmc protein retains function when expressed). This causes large reduction of T-synthase protein and activity in a cell/tissue-specific manner, leading to Tn-antigen expression on multiple glycoproteins, elevated galactose-deficient IgA1, and multisystem disease. Transient transfection of patient cells with WT C1GALT1C1 partially rescued T-synthase and glycosylation defect.","method":"Patient genetic analysis, Cosmc and T-synthase protein expression by Western blot, T-synthase activity assay, O-glycan profiling, transient transfection rescue experiment","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1–2 / Moderate — human patient variant studied with functional assays, transfection rescue, and glycan profiling; demonstrates TMD mutation causes expression defect rather than activity defect","pmids":["37216524"],"is_preprint":false},{"year":2023,"finding":"SLC35A2 (UDP-galactose transporter) associates with Cosmc as well as with C1GalT1 (T-synthase). In SLC35A2-deficient cells, protein levels of both C1GalT1 and Cosmc are decreased and their Golgi localization is less pronounced, suggesting NSTs contribute to stabilization and targeting of Cosmc and its client.","method":"Co-immunoprecipitation, Western blot in SLC35A2 KO cells, immunofluorescence localization","journal":"Biochimica et biophysica acta. Molecular cell research","confidence":"Medium","confidence_rationale":"Tier 3 / Weak — co-IP demonstrates association but indirect evidence for functional consequence; single lab study","pmids":["36933771"],"is_preprint":false},{"year":2015,"finding":"COSMC knockdown in pancreatic cancer cell lines via lentiviral shRNA reduces proliferation, increases migration, and decreases apoptosis. Nucleolin is identified as a novel O-GalNAc-modified protein in COSMC-deficient PDAC cell lines.","method":"Lentiviral shRNA knockdown, cell viability/migration/apoptosis assays, lectin-based glycoprotein enrichment with mass spectrometry, Western/Far-Western blot","journal":"Molecular cancer","confidence":"Medium","confidence_rationale":"Tier 2–3 / Moderate — KD with multiple phenotypic readouts and MS identification of substrate, but pathway from aberrant glycosylation to phenotype not fully resolved","pmids":["26021314"],"is_preprint":false},{"year":2020,"finding":"Cosmc disruption via CRISPR/Cas9 in breast cancer cells (MCF7, T47D) suppresses cell growth in vitro and in vivo. Mechanistically, Cosmc deficiency impairs protein expression of CD44 and the associated MAPK signaling pathway; reconstitution of CD44 substantially reverses these alterations, demonstrating that CD44 requires normal O-glycosylation for proper expression and signaling.","method":"CRISPR/Cas9 Cosmc deletion, RTCA proliferation assay, colony formation, in vivo xenograft, Western blot for CD44 and MAPK pathway, CD44 reconstitution rescue","journal":"Cancer management and research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — CRISPR KO with rescue experiment identifies CD44 as mechanistic link, in vitro and in vivo validation","pmids":["32158257"],"is_preprint":false},{"year":2016,"finding":"TNF-α downregulates COSMC mRNA and protein expression and induces hypermethylation of CpG islands in the COSMC gene promoter, leading to elevated Tn antigen levels. This defines a cytokine-Cosmc-Tn signaling axis.","method":"Cytokine treatment of gingival fibroblasts, RT-PCR and Western blot for COSMC, methylation-specific PCR/bisulfite sequencing of COSMC promoter, Tn antigen immunostaining","journal":"Oncotarget","confidence":"Medium","confidence_rationale":"Tier 2–3 / Weak — single lab, single study linking TNF-α to COSMC promoter methylation, but mechanistically shows epigenetic regulation by inflammatory cytokine","pmids":["27542280"],"is_preprint":false},{"year":2024,"finding":"Hepatocyte-specific deletion of Cosmc in mice abolishes extended O-glycans on liver glycoproteins and causes expression of Tn antigen on hepatocyte-derived membrane glycoproteins and serum glycoproteins. The LDL receptor (LDLR), an O-glycosylated hepatocyte glycoprotein, is reduced from ~145 kDa to ~120 kDa in the absence of Cosmc-dependent glycosylation, but LDLR expression, HMG-CoA reductase expression, and cholesterol metabolism are unaffected, indicating that core 1 O-glycans on LDLR are not required for its stability or function.","method":"Hepatocyte-specific conditional Cosmc KO mouse, Western blot for LDLR and HMG-CoA reductase, O-glycan profiling, Tn antigen detection in serum","journal":"Glycobiology","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — conditional KO with biochemical characterization, single study defining hepatic O-glycan substrate landscape","pmids":["39216105"],"is_preprint":false},{"year":2020,"finding":"COSMC coding mutations in advanced Alzheimer's disease brain tissue result in significantly reduced T-synthase activity (3-fold lower than advanced AD without mutations), demonstrating that somatic COSMC mutations can impair T-synthase function in brain tissue.","method":"Sequencing of COSMC in brain tissue, Q-RT-PCR, Western blotting, T-synthase activity assay","journal":"Alzheimer's & dementia (New York, N. Y.)","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — direct T-synthase activity assay in patient tissue correlating with COSMC mutations, but single study without mechanistic follow-up","pmids":["32607408"],"is_preprint":false}],"current_model":"C1GALT1C1/Cosmc encodes an X-linked, ER-resident type II transmembrane molecular chaperone that is the sole dedicated chaperone for T-synthase (core 1 β3-galactosyltransferase/C1GALT1): Cosmc binds co-translationally to a specific hydrophobic recognition motif (CBRT) in the N-terminal stem of newly synthesized T-synthase, prevents its aggregation and ubiquitin-proteasome-mediated degradation, promotes ATP-independent refolding, and directs T-synthase to the Golgi apparatus, where T-synthase catalyzes the addition of galactose to the Tn antigen to generate the core 1 O-glycan (T antigen) precursor for all extended mucin-type O-glycans; loss of Cosmc function—through somatic mutation, germline mutation, promoter hypermethylation (driven by SP1/SP3 sites), or cytokine/epigenetic suppression—abolishes T-synthase activity and causes global expression of the Tn antigen, with consequences ranging from embryonic lethality and autoimmunity to cancer progression and organ-specific pathologies including IgA nephropathy and hemolytic uremic syndrome."},"narrative":{"mechanistic_narrative":"C1GALT1C1 (Cosmc) is an endoplasmic reticulum-resident molecular chaperone dedicated to folding and activating T-synthase (core 1 β3-galactosyltransferase/C1GALT1), the enzyme that builds the core 1 O-glycan (T antigen) precursor for all extended mucin-type O-glycans [PMID:12464682, PMID:18695044]. Cosmc binds a cryptic hydrophobic recognition motif (CBRT) in the N-terminal stem of non-native T-synthase, prevents its aggregation and ubiquitin-proteasome-mediated degradation, and promotes ATP-independent refolding, with reactivation operating through a client-driven dissociation cycle [PMID:19923218, PMID:22416136, PMID:24616093]; in the absence of Cosmc, T-synthase fails to reach the Golgi and is degraded [PMID:12464682, PMID:18061573]. Its structured N-terminal domain mediates client binding while the C-terminal domain governs oligomerization and divalent-cation binding, and a transmembrane Cys-dependent disulfide dimer enforces ER retention [PMID:21262965, PMID:28665962]. Loss of Cosmc function—via somatic mutation with loss of heterozygosity, promoter CpG hypermethylation, or transcriptional silencing—abolishes T-synthase activity and produces global Tn/sialyl-Tn antigen expression in cancers and other pathologies [PMID:18339842, PMID:23035125, PMID:26063800]. Basal transcription is driven by SP1/SP3 sites within the core promoter and is suppressed by inflammatory cytokine-induced promoter methylation [PMID:26063800, PMID:27542280]. In vivo, Cosmc is required embryonically and tissue-specifically: it controls intestinal mucus integrity and microbiota biogeography, B and T cell trafficking and BCR signaling/tolerance, and podocyte function, with several phenotypes arising cell non-autonomously [PMID:20439703, PMID:27930307, PMID:32778659, PMID:34613773, PMID:31904283]. A germline transmembrane-domain variant (p.Ala20Asp) that reduces Cosmc protein expression causes multisystem disease with galactose-deficient IgA1, establishing a direct human disease link [PMID:37216524].","teleology":[{"year":2002,"claim":"Established that core 1 O-glycosylation depends not only on a glycosyltransferase but on a dedicated partner, by showing T-synthase activity requires Cosmc and is otherwise lost to proteasomal degradation.","evidence":"Co-purification, cDNA rescue in Cosmc-mutant Jurkat cells, insect-cell co-expression, proteasome inhibitors","pmids":["12464682"],"confidence":"High","gaps":["Mechanism of T-synthase recognition not yet defined","Subcellular site of action not resolved in this study"]},{"year":2007,"claim":"Resolved where the chaperone and client act, showing Cosmc is ER-localized while T-synthase functions in the Golgi and requires Cosmc for proper Golgi targeting.","evidence":"Immunocytochemistry, lactacystin proteasome inhibition, Cosmc overexpression rescue in colon cancer cells","pmids":["18061573"],"confidence":"High","gaps":["Trafficking machinery handing off T-synthase from ER to Golgi unidentified","How Cosmc is retained in ER not yet defined"]},{"year":2008,"claim":"Defined the biochemical chaperone mechanism, demonstrating Cosmc directly binds T-synthase, prevents aggregation, and blocks its ubiquitin-mediated degradation, and clinically linked somatic Cosmc loss to tumor Tn/STn antigen expression.","evidence":"ATP-binding assays, ubiquitination assays, direct binding; plus Cosmc sequencing/LOH analysis in cancer cell lines and tumor specimens","pmids":["18695044","18339842"],"confidence":"High","gaps":["Functional role of ATP binding not established","Whether Tn expression drives or merely marks malignancy unresolved"]},{"year":2009,"claim":"Reconstituted the chaperone reaction in vitro, proving Cosmc's lumenal domain binds denatured T-synthase and restores activity ATP-independently, and that a disease-associated mutant is functionally impaired.","evidence":"In vitro refolding and solid-support binding assays with recombinant proteins, mutant comparison","pmids":["19923218"],"confidence":"High","gaps":["Structural basis of binding not determined","Energetics of refolding without ATP unexplained"]},{"year":2010,"claim":"Demonstrated in vivo specificity and physiological essentiality, showing germline Cosmc ablation is embryonic lethal and selectively eliminates T-synthase among glycosylation enzymes.","evidence":"Germline/conditional mouse knockout, Tn immunostaining, enzyme activity and Western blots","pmids":["20439703"],"confidence":"High","gaps":["Cause of embryonic lethality not pinpointed","Tissue-specific requirements not yet dissected"]},{"year":2011,"claim":"Defined the timing and structural determinant of ER retention, showing Cosmc acts co-translationally and uses a TMD Cys-dependent disulfide dimer for ER retention.","evidence":"Wheat-germ cell-free translation timing experiments; chimeric proteins with TfR and TMD Cys mutagenesis","pmids":["21496458","21262965"],"confidence":"Medium","gaps":["Co-translational mechanism shown in single cell-free study","Whether dimerization is required for chaperone activity per se unclear"]},{"year":2012,"claim":"Established the chaperone cycle, showing Cosmc selectively binds non-native (not active dimeric) T-synthase and is released through client-driven competition with additional T-synthase molecules.","evidence":"In vitro binding/reactivation and competition assays with recombinant Cosmc lumenal domain","pmids":["22416136"],"confidence":"High","gaps":["Stoichiometry of the in vivo cycle not measured","Co-factors regulating release not identified"]},{"year":2012,"claim":"Identified epigenetic silencing as a mechanism of functional loss, showing Cosmc promoter CpG hypermethylation abolishes transcripts and T-synthase activity, reversibly.","evidence":"Bisulfite sequencing, 5-aza-2'-deoxycytidine rescue, RT-PCR, activity and Tn assays in Tn4 B cells","pmids":["23035125"],"confidence":"High","gaps":["Trigger initiating hypermethylation not defined here","Generality across cell types not established"]},{"year":2014,"claim":"Mapped the client recognition element, identifying CBRT in the T-synthase N-terminal stem as the Cosmc-binding motif sufficient to confer Cosmc dependence on a heterologous transferase.","evidence":"Deletion/point mutagenesis, synthetic peptide binding, refolding inhibition, β4GalT1 domain-swap chimera","pmids":["24616093"],"confidence":"High","gaps":["Atomic-resolution structure of the Cosmc-CBRT interface lacking","Why CBRT is cryptic in native enzyme not explained"]},{"year":2015,"claim":"Defined transcriptional control of Cosmc, identifying SP1/SP3 sites in the core promoter driving basal expression and confirming selective promoter hypermethylation in silenced cells.","evidence":"Luciferase reporters, SP1/SP3 site mutagenesis, ChIP, mithramycin A, methylome analysis","pmids":["26063800"],"confidence":"High","gaps":["Inducible/tissue-specific regulators beyond SP1/SP3 unknown","Link between methylation and TF occupancy not directly shown"]},{"year":2017,"claim":"Delineated Cosmc domain architecture, separating an N-terminal chaperone domain from a C-terminal oligomerization/metal-binding domain and revealing a disease mutant active in vitro yet defective in vivo.","evidence":"Limited proteolysis, crosslinking, blue native PAGE, thermal shift, truncation/point-mutant chaperone assays","pmids":["28665962"],"confidence":"High","gaps":["Functional role of oligomerization and metal binding unresolved","Why E152K fails in vivo despite in vitro activity unexplained"]},{"year":2023,"claim":"Connected Cosmc to human Mendelian disease, showing a TMD variant (A20D) lowers Cosmc protein levels causing T-synthase loss, Tn antigen, galactose-deficient IgA1, and multisystem pathology.","evidence":"Patient genetics, Cosmc/T-synthase Western and activity assays, O-glycan profiling, transfection rescue","pmids":["37216524"],"confidence":"High","gaps":["Mechanism by which TMD variant lowers protein expression not detailed","Tissue specificity of the defect incompletely explained"]},{"year":2023,"claim":"Implicated the UDP-galactose transporter in Cosmc/T-synthase stability, showing SLC35A2 associates with both and that its loss reduces their levels and Golgi localization.","evidence":"Co-immunoprecipitation, Western blot in SLC35A2 KO cells, immunofluorescence","pmids":["36933771"],"confidence":"Medium","gaps":["Co-IP without reciprocal validation of direct binding","Causal mechanism linking transporter loss to chaperone destabilization untested"]},{"year":2021,"claim":"Linked Cosmc-dependent O-glycosylation to immune homeostasis across tissues, showing it is required for B and T cell peripheral establishment/trafficking, BCR signaling restraint, intestinal mucus/microbiota, and podocyte function, often cell non-autonomously.","evidence":"Lineage-specific conditional knockouts (B cell, T cell, intestinal epithelium, podocyte) with adoptive transfer, intravital imaging, microbiome sequencing, mosaic-female analysis","pmids":["27930307","32778659","31317176","34613773","31904283"],"confidence":"High","gaps":["Specific glycoprotein effectors in each tissue incompletely defined","Molecular basis of cell non-autonomous rescue not fully resolved"]},{"year":2024,"claim":"Began cataloguing tissue O-glycoprotein substrate landscapes and disease associations, identifying VEGFR2, CD44, nucleolin, podocalyxin/podoplanin, and LDLR as Cosmc-dependent glycoproteins with context-specific functional consequences.","evidence":"Conditional/CRISPR/shRNA Cosmc loss in endothelial, breast, pancreatic, podocyte, and hepatocyte systems with glycoprotein profiling and rescue","pmids":["23424651","32158257","26021314","31904283","39216105"],"confidence":"Medium","gaps":["Direct mechanistic link from altered O-glycan to each phenotype not fully established","Several substrate findings from single labs without reciprocal validation"]},{"year":null,"claim":"How somatic and cytokine-driven Cosmc loss mechanistically contributes to specific disease pathologies, and the atomic structure of the Cosmc–T-synthase complex, remain open.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No high-resolution structure of Cosmc or the chaperone-client complex","Causal chain from Tn antigen exposure to organ pathology incompletely defined"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0044183","term_label":"protein folding chaperone","supporting_discovery_ids":[0,2,4,8]},{"term_id":"GO:0140096","term_label":"catalytic activity, acting on a protein","supporting_discovery_ids":[2,4,11]},{"term_id":"GO:0140657","term_label":"ATP-dependent activity","supporting_discovery_ids":[2]}],"localization":[{"term_id":"GO:0005783","term_label":"endoplasmic reticulum","supporting_discovery_ids":[2,6,10]}],"pathway":[{"term_id":"R-HSA-392499","term_label":"Metabolism of proteins","supporting_discovery_ids":[0,2,4]},{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[17,19,20]}],"complexes":[],"partners":["C1GALT1","SLC35A2"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"Q96EU7","full_name":"C1GALT1-specific chaperone 1","aliases":["C38H2-like protein 1","C38H2-L1","Core 1 beta1,3-galactosyltransferase 2","C1Gal-T2","C1GalT2","Core 1 beta3-Gal-T2","Core 1 beta3-galactosyltransferase-specific molecular chaperone"],"length_aa":318,"mass_kda":36.4,"function":"Probable chaperone required for the generation of 1 O-glycan Gal-beta1-3GalNAc-alpha1-Ser/Thr (T antigen), which is a precursor for many extended O-glycans in glycoproteins. Probably acts as a specific molecular chaperone assisting the folding/stability of core 1 beta-3-galactosyltransferase (C1GALT1)","subcellular_location":"Membrane","url":"https://www.uniprot.org/uniprotkb/Q96EU7/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/C1GALT1C1","classification":"Not Classified","n_dependent_lines":0,"n_total_lines":1208,"dependency_fraction":0.0},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[{"gene":"CANX","stoichiometry":0.2}],"url":"https://opencell.sf.czbiohub.org/search/C1GALT1C1","total_profiled":1310},"omim":[{"mim_id":"610555","title":"CORE 1 SYNTHASE, GLYCOPROTEIN-N-ACETYLGALACTOSAMINE 3-BETA-GALACTOSYLTRANSFERASE, 1; C1GALT1","url":"https://www.omim.org/entry/610555"},{"mim_id":"301110","title":"HEMOLYTIC UREMIC SYNDROME, ATYPICAL, 8, WITH RHIZOMELIC SHORT STATURE; AHUS8","url":"https://www.omim.org/entry/301110"},{"mim_id":"300622","title":"TN POLYAGGLUTINATION SYNDROME; TNPS","url":"https://www.omim.org/entry/300622"},{"mim_id":"300611","title":"C1GALT1-SPECIFIC CHAPERONE 1; C1GALT1C1","url":"https://www.omim.org/entry/300611"},{"mim_id":"235400","title":"HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 1; AHUS1","url":"https://www.omim.org/entry/235400"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Vesicles","reliability":"Approved"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/C1GALT1C1"},"hgnc":{"alias_symbol":["COSMC","C1GALT2"],"prev_symbol":[]},"alphafold":{"accession":"Q96EU7","domains":[{"cath_id":"3.90.550.50","chopping":"42-293","consensus_level":"high","plddt":92.3206,"start":42,"end":293}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q96EU7","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q96EU7-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q96EU7-F1-predicted_aligned_error_v6.png","plddt_mean":87.19},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=C1GALT1C1","jax_strain_url":"https://www.jax.org/strain/search?query=C1GALT1C1"},"sequence":{"accession":"Q96EU7","fasta_url":"https://rest.uniprot.org/uniprotkb/Q96EU7.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q96EU7/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q96EU7"}},"corpus_meta":[{"pmid":"12464682","id":"PMC_12464682","title":"A unique molecular chaperone Cosmc required for activity of the mammalian core 1 beta 3-galactosyltransferase.","date":"2002","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/12464682","citation_count":402,"is_preprint":false},{"pmid":"18339842","id":"PMC_18339842","title":"Human tumor antigens Tn and sialyl Tn arise from mutations in Cosmc.","date":"2008","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/18339842","citation_count":241,"is_preprint":false},{"pmid":"20439703","id":"PMC_20439703","title":"Cosmc is an essential chaperone for correct protein O-glycosylation.","date":"2010","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/20439703","citation_count":171,"is_preprint":false},{"pmid":"24643043","id":"PMC_24643043","title":"The Cosmc connection to the Tn antigen in cancer.","date":"2014","source":"Cancer biomarkers : section A of Disease markers","url":"https://pubmed.ncbi.nlm.nih.gov/24643043","citation_count":127,"is_preprint":false},{"pmid":"18695044","id":"PMC_18695044","title":"Regulation of protein O-glycosylation by the endoplasmic reticulum-localized molecular chaperone Cosmc.","date":"2008","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/18695044","citation_count":109,"is_preprint":false},{"pmid":"26021314","id":"PMC_26021314","title":"COSMC knockdown mediated aberrant O-glycosylation promotes oncogenic properties in pancreatic cancer.","date":"2015","source":"Molecular cancer","url":"https://pubmed.ncbi.nlm.nih.gov/26021314","citation_count":101,"is_preprint":false},{"pmid":"25951175","id":"PMC_25951175","title":"The Breast Cancer-Associated Glycoforms of MUC1, MUC1-Tn and sialyl-Tn, Are Expressed in COSMC Wild-Type Cells and Bind the C-Type Lectin MGL.","date":"2015","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/25951175","citation_count":82,"is_preprint":false},{"pmid":"20551088","id":"PMC_20551088","title":"Down-regulation of core 1 beta1,3-galactosyltransferase and Cosmc by Th2 cytokine alters O-glycosylation of IgA1.","date":"2010","source":"Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association","url":"https://pubmed.ncbi.nlm.nih.gov/20551088","citation_count":79,"is_preprint":false},{"pmid":"18202089","id":"PMC_18202089","title":"External suppression causes the low expression of the Cosmc gene in IgA nephropathy.","date":"2008","source":"Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association","url":"https://pubmed.ncbi.nlm.nih.gov/18202089","citation_count":76,"is_preprint":false},{"pmid":"27930307","id":"PMC_27930307","title":"Cosmc is an X-linked inflammatory bowel disease risk gene that spatially regulates gut microbiota and contributes to sex-specific risk.","date":"2016","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/27930307","citation_count":73,"is_preprint":false},{"pmid":"12361956","id":"PMC_12361956","title":"Molecular cloning and characterization of a novel UDP-Gal:GalNAc(alpha) peptide beta 1,3-galactosyltransferase (C1Gal-T2), an enzyme synthesizing a core 1 structure of O-glycan.","date":"2002","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12361956","citation_count":63,"is_preprint":false},{"pmid":"19923218","id":"PMC_19923218","title":"The endoplasmic reticulum chaperone Cosmc directly promotes in vitro folding of T-synthase.","date":"2009","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/19923218","citation_count":61,"is_preprint":false},{"pmid":"23035125","id":"PMC_23035125","title":"Epigenetic silencing of the chaperone Cosmc in human leukocytes expressing tn antigen.","date":"2012","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/23035125","citation_count":57,"is_preprint":false},{"pmid":"30115016","id":"PMC_30115016","title":"Differential expression of Cosmc, T-synthase and mucins in Tn-positive colorectal cancers.","date":"2018","source":"BMC cancer","url":"https://pubmed.ncbi.nlm.nih.gov/30115016","citation_count":52,"is_preprint":false},{"pmid":"18537974","id":"PMC_18537974","title":"New mutations in C1GALT1C1 in individuals with Tn positive phenotype.","date":"2008","source":"British journal of haematology","url":"https://pubmed.ncbi.nlm.nih.gov/18537974","citation_count":36,"is_preprint":false},{"pmid":"25647400","id":"PMC_25647400","title":"DNA methylation in Cosmc promoter region and aberrantly glycosylated IgA1 associated with pediatric IgA nephropathy.","date":"2015","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/25647400","citation_count":31,"is_preprint":false},{"pmid":"22416136","id":"PMC_22416136","title":"Tight complex formation between Cosmc chaperone and its specific client non-native T-synthase leads to enzyme activity and client-driven dissociation.","date":"2012","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/22416136","citation_count":29,"is_preprint":false},{"pmid":"23390052","id":"PMC_23390052","title":"The molecular chaperone Cosmc enhances malignant behaviors of colon cancer cells via activation of Akt and ERK.","date":"2013","source":"Molecular carcinogenesis","url":"https://pubmed.ncbi.nlm.nih.gov/23390052","citation_count":27,"is_preprint":false},{"pmid":"32778659","id":"PMC_32778659","title":"Cosmc controls B cell homing.","date":"2020","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/32778659","citation_count":24,"is_preprint":false},{"pmid":"26063800","id":"PMC_26063800","title":"Promoters of Human Cosmc and T-synthase Genes Are Similar in Structure, Yet Different in Epigenetic Regulation.","date":"2015","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/26063800","citation_count":24,"is_preprint":false},{"pmid":"18840896","id":"PMC_18840896","title":"No evidence for a role of cosmc-chaperone mutations in European IgA nephropathy patients.","date":"2008","source":"Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association","url":"https://pubmed.ncbi.nlm.nih.gov/18840896","citation_count":23,"is_preprint":false},{"pmid":"31904283","id":"PMC_31904283","title":"Cosmc-dependent mucin-type O-linked glycosylation is essential for podocyte function.","date":"2020","source":"American journal of physiology. Renal physiology","url":"https://pubmed.ncbi.nlm.nih.gov/31904283","citation_count":22,"is_preprint":false},{"pmid":"26045765","id":"PMC_26045765","title":"Aberrant Cosmc genes result in Tn antigen expression in human colorectal carcinoma cell line HT-29.","date":"2015","source":"International journal of clinical and experimental pathology","url":"https://pubmed.ncbi.nlm.nih.gov/26045765","citation_count":19,"is_preprint":false},{"pmid":"24616093","id":"PMC_24616093","title":"Identification of a novel protein binding motif within the T-synthase for the molecular chaperone Cosmc.","date":"2014","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/24616093","citation_count":19,"is_preprint":false},{"pmid":"24942185","id":"PMC_24942185","title":"Astragalus membranaceus up-regulate Cosmc expression and reverse IgA dys-glycosylation in IgA nephropathy.","date":"2014","source":"BMC complementary and alternative medicine","url":"https://pubmed.ncbi.nlm.nih.gov/24942185","citation_count":18,"is_preprint":false},{"pmid":"21262965","id":"PMC_21262965","title":"The transmembrane domain of the molecular chaperone Cosmc directs its localization to the endoplasmic reticulum.","date":"2011","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/21262965","citation_count":18,"is_preprint":false},{"pmid":"31633299","id":"PMC_31633299","title":"Cosmc overexpression enhances malignancies in human colon cancer.","date":"2019","source":"Journal of cellular and molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/31633299","citation_count":17,"is_preprint":false},{"pmid":"23424651","id":"PMC_23424651","title":"COSMC is overexpressed in proliferating infantile hemangioma and enhances endothelial cell growth via VEGFR2.","date":"2013","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/23424651","citation_count":17,"is_preprint":false},{"pmid":"23136028","id":"PMC_23136028","title":"Mycophenolic acid reverses IgA1 aberrant glycosylation through up-regulating Cosmc expression in IgA nephropathy.","date":"2012","source":"International urology and nephrology","url":"https://pubmed.ncbi.nlm.nih.gov/23136028","citation_count":17,"is_preprint":false},{"pmid":"37216524","id":"PMC_37216524","title":"Germline C1GALT1C1 mutation causes a multisystem chaperonopathy.","date":"2023","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/37216524","citation_count":16,"is_preprint":false},{"pmid":"32158257","id":"PMC_32158257","title":"Cosmc Disruption-Mediated Aberrant O-glycosylation Suppresses Breast Cancer Cell Growth via Impairment of CD44.","date":"2020","source":"Cancer management and research","url":"https://pubmed.ncbi.nlm.nih.gov/32158257","citation_count":15,"is_preprint":false},{"pmid":"28665962","id":"PMC_28665962","title":"Biochemical characterization of functional domains of the chaperone Cosmc.","date":"2017","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/28665962","citation_count":15,"is_preprint":false},{"pmid":"20144270","id":"PMC_20144270","title":"The role of C1GALT1C1 in lipopolysaccharide-induced IgA1 aberrant O-glycosylation in IgA nephropathy.","date":"2010","source":"Clinical and investigative medicine. Medecine clinique et experimentale","url":"https://pubmed.ncbi.nlm.nih.gov/20144270","citation_count":15,"is_preprint":false},{"pmid":"18061573","id":"PMC_18061573","title":"Immunocytochemical analysis for intracellular dynamics of C1GalT associated with molecular chaperone, Cosmc.","date":"2007","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/18061573","citation_count":14,"is_preprint":false},{"pmid":"28035353","id":"PMC_28035353","title":"TGF-β1 mimics the effect of IL-4 on the glycosylation of IgA1 by downregulating core 1 β1, 3-galactosyltransferase and Cosmc.","date":"2016","source":"Molecular medicine reports","url":"https://pubmed.ncbi.nlm.nih.gov/28035353","citation_count":13,"is_preprint":false},{"pmid":"36551160","id":"PMC_36551160","title":"Emerging Roles of the Unique Molecular Chaperone Cosmc in the Regulation of Health and Disease.","date":"2022","source":"Biomolecules","url":"https://pubmed.ncbi.nlm.nih.gov/36551160","citation_count":10,"is_preprint":false},{"pmid":"21496458","id":"PMC_21496458","title":"Co-translational function of Cosmc, core 1 synthase specific molecular chaperone, revealed by a cell-free translation system.","date":"2011","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/21496458","citation_count":10,"is_preprint":false},{"pmid":"31317176","id":"PMC_31317176","title":"Cosmc is required for T cell persistence in the periphery.","date":"2019","source":"Glycobiology","url":"https://pubmed.ncbi.nlm.nih.gov/31317176","citation_count":9,"is_preprint":false},{"pmid":"32607408","id":"PMC_32607408","title":"COSMC mutations reduce T-synthase activity in advanced Alzheimer's disease.","date":"2020","source":"Alzheimer's & dementia (New York, N. Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/32607408","citation_count":9,"is_preprint":false},{"pmid":"19778426","id":"PMC_19778426","title":"Do the mutations of C1GALT1C1 gene play important roles in the genetic susceptibility to Chinese IgA nephropathy?","date":"2009","source":"BMC medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/19778426","citation_count":9,"is_preprint":false},{"pmid":"36933771","id":"PMC_36933771","title":"SLC35A2 deficiency reduces protein levels of core 1 β-1,3-galactosyltransferase 1 (C1GalT1) and its chaperone Cosmc and affects their subcellular localization.","date":"2023","source":"Biochimica et biophysica acta. Molecular cell research","url":"https://pubmed.ncbi.nlm.nih.gov/36933771","citation_count":8,"is_preprint":false},{"pmid":"34613773","id":"PMC_34613773","title":"Cosmc deficiency causes spontaneous autoimmunity by breaking B cell tolerance.","date":"2021","source":"Science advances","url":"https://pubmed.ncbi.nlm.nih.gov/34613773","citation_count":8,"is_preprint":false},{"pmid":"38151955","id":"PMC_38151955","title":"Hydroxychloroquine ameliorates immune functionality and intestinal flora disorders of IgA nephropathy by inhibition of C1GALT1/Cosmc pathway.","date":"2024","source":"Immunopharmacology and immunotoxicology","url":"https://pubmed.ncbi.nlm.nih.gov/38151955","citation_count":8,"is_preprint":false},{"pmid":"32104083","id":"PMC_32104083","title":"Demethylation of the Cosmc Promoter Alleviates the Progression of Breast Cancer Through Downregulation of the Tn and Sialyl-Tn Antigens.","date":"2020","source":"Cancer management and research","url":"https://pubmed.ncbi.nlm.nih.gov/32104083","citation_count":8,"is_preprint":false},{"pmid":"36599939","id":"PMC_36599939","title":"X-linked C1GALT1C1 mutation causes atypical hemolytic uremic syndrome.","date":"2023","source":"European journal of human genetics : EJHG","url":"https://pubmed.ncbi.nlm.nih.gov/36599939","citation_count":7,"is_preprint":false},{"pmid":"28708980","id":"PMC_28708980","title":"CD3/CD28 dynabeads induce expression of tn antigen in human t cells accompanied by hypermethylation of the cosmc promoter.","date":"2017","source":"Molecular immunology","url":"https://pubmed.ncbi.nlm.nih.gov/28708980","citation_count":7,"is_preprint":false},{"pmid":"22332537","id":"PMC_22332537","title":"[Effect of methylation modification on the expression of Cosmc gene in peripheral B lymphocyte of IgA nephropathy patients].","date":"2011","source":"Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition","url":"https://pubmed.ncbi.nlm.nih.gov/22332537","citation_count":7,"is_preprint":false},{"pmid":"32452513","id":"PMC_32452513","title":"Overexpression of Cosmc suppresses cell migration and invasion in different subtypes of breast cancer cells via Tn and T glycans.","date":"2020","source":"Bioscience reports","url":"https://pubmed.ncbi.nlm.nih.gov/32452513","citation_count":6,"is_preprint":false},{"pmid":"20816162","id":"PMC_20816162","title":"Functional assays for the molecular chaperone cosmc.","date":"2010","source":"Methods in enzymology","url":"https://pubmed.ncbi.nlm.nih.gov/20816162","citation_count":6,"is_preprint":false},{"pmid":"27542280","id":"PMC_27542280","title":"The cytokine-cosmc signaling axis upregulates the tumor-associated carbohydrate antigen Tn.","date":"2016","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/27542280","citation_count":5,"is_preprint":false},{"pmid":"32186752","id":"PMC_32186752","title":"MicroRNA‑196b targets COSMC in pediatric IgA nephropathy.","date":"2020","source":"Molecular medicine reports","url":"https://pubmed.ncbi.nlm.nih.gov/32186752","citation_count":4,"is_preprint":false},{"pmid":"34644263","id":"PMC_34644263","title":"Cosmc transfection decreases malignant behavior of Tn+ cells and enhances sensitivity to apoptosis when induced by Apo2L/TRAIL via alteration of O-glycan structure.","date":"2021","source":"Aging","url":"https://pubmed.ncbi.nlm.nih.gov/34644263","citation_count":4,"is_preprint":false},{"pmid":"31250447","id":"PMC_31250447","title":"Serum level of advanced oxidation protein products (AOPPs) in patients with Henoch-Schonlein purpura and its relationship with aberrant glycosylation of IgA1 and Cosmc mRNA expression.","date":"2019","source":"International journal of dermatology","url":"https://pubmed.ncbi.nlm.nih.gov/31250447","citation_count":4,"is_preprint":false},{"pmid":"39216105","id":"PMC_39216105","title":"Cosmc regulates O-glycan extension in murine hepatocytes.","date":"2024","source":"Glycobiology","url":"https://pubmed.ncbi.nlm.nih.gov/39216105","citation_count":3,"is_preprint":false},{"pmid":"32683071","id":"PMC_32683071","title":"The Cosmc-mediated effects of neutrophil elastase on T antigen expression in BEAS-2B cells.","date":"2020","source":"Respiratory physiology & neurobiology","url":"https://pubmed.ncbi.nlm.nih.gov/32683071","citation_count":3,"is_preprint":false},{"pmid":"36306048","id":"PMC_36306048","title":"COSMC expression as a predictor of remission in IgA nephropathy.","date":"2022","source":"International urology and nephrology","url":"https://pubmed.ncbi.nlm.nih.gov/36306048","citation_count":2,"is_preprint":false},{"pmid":"32132294","id":"PMC_32132294","title":"Effects of non-caloric ultrashort wave on the expression of CoQ10 and C1GALT1C1 in rats with cerebral ischemia reperfusion injury.","date":"2020","source":"Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences","url":"https://pubmed.ncbi.nlm.nih.gov/32132294","citation_count":2,"is_preprint":false},{"pmid":"39949072","id":"PMC_39949072","title":"C1GALT1C1-Associated Mosaic Disorder of Glycosylation in a Female.","date":"2025","source":"Journal of inherited metabolic disease","url":"https://pubmed.ncbi.nlm.nih.gov/39949072","citation_count":1,"is_preprint":false},{"pmid":"27412546","id":"PMC_27412546","title":"[Association of Cosmc gene mutation with susceptibility to Henoch-Schönlein purpura in children].","date":"2016","source":"Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics","url":"https://pubmed.ncbi.nlm.nih.gov/27412546","citation_count":0,"is_preprint":false},{"pmid":"41759737","id":"PMC_41759737","title":"Deletion of Core 1 β3GalT-specific molecular chaperone (Cosmc) in murine intestinal epithelia leads to major alterations in glycocalyx and tumorigenesis.","date":"2026","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/41759737","citation_count":0,"is_preprint":false},{"pmid":"42245127","id":"PMC_42245127","title":"LncSLED1 inhibits monosodium urate-induced macrophage inflammation by promoting Cosmc methylation to upregulate CA72-4.","date":"2026","source":"Central-European journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/42245127","citation_count":0,"is_preprint":false},{"pmid":null,"id":"bio_10.1101_2025.03.22.644720","title":"A humanized 16A antibody conjugated with DNA topoisomerase I inhibitors, targeting a GSTA glycosite-signature epitope","date":"2025-03-25","source":"bioRxiv","url":"https://doi.org/10.1101/2025.03.22.644720","citation_count":0,"is_preprint":true}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":33993,"output_tokens":7714,"usd":0.108844,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":17282,"output_tokens":4704,"usd":0.102005,"stage2_stop_reason":"end_turn"},"total_usd":0.210849,"stage1_batch_id":"msgbatch_0179Z2pxRYBsXi2xADneafRw","stage2_batch_id":"msgbatch_01LaY9ZaVdgjWArcZo9eqQE5","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2002,\n      \"finding\": \"Cosmc (C1GALT1C1) is a specific molecular chaperone required for the activity of core 1 β3-galactosyltransferase (T-synthase/C1beta3Gal-T). Without Cosmc, T-synthase is targeted to proteasomes and degraded. A small portion of T-synthase co-purifies with Cosmc from cell extracts, demonstrating direct physical association. Expression of Cosmc cDNA in Jurkat cells (which carry a mutated Cosmc with a premature stop codon) restored T-synthase activity and T antigen expression.\",\n      \"method\": \"Co-purification from cell extracts, cDNA rescue in Cosmc-mutant Jurkat cells, co-expression in insect cells, proteasome inhibitor studies\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — multiple orthogonal methods (co-purification, genetic rescue, insect cell reconstitution), foundational paper replicated by subsequent studies\",\n      \"pmids\": [\"12464682\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"C1Gal-T2 (an alias for C1GALT1C1 as used in this paper, but note: this paper describes a paralog C1Gal-T2 with 26% homology to C1Gal-T1 that also has core 1 synthase activity). LSC and Jurkat cells lacking core 1 synthase activity were found to have null alleles of C1Gal-T2, indicating C1Gal-T2 contributes to core 1 O-glycan synthesis.\",\n      \"method\": \"Stable transfection of LSC cells, microsome enzyme activity assay, flow cytometry, lectin blotting, allele sequencing\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — enzyme activity assay in transfected cells plus allele analysis, single lab; note this paper describes the C1Gal-T2 paralog/isoform with independent catalytic activity\",\n      \"pmids\": [\"12361956\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"Cosmc is an endoplasmic reticulum (ER)-localized, ATP-binding molecular chaperone that directly binds to human T-synthase, prevents its aggregation, and blocks ubiquitin-mediated degradation of T-synthase.\",\n      \"method\": \"Subcellular fractionation and immunolocalization, ATP-binding assays, ubiquitination assays, direct binding experiments\",\n      \"journal\": \"The Journal of cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — direct binding demonstrated, ER localization established by fractionation, ubiquitin-mediated degradation pathway defined with multiple methods\",\n      \"pmids\": [\"18695044\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"Somatic loss-of-function mutations in Cosmc cause expression of tumor-associated Tn and sialyl-Tn (STn) antigens in diverse neoplastic cell lines (colon cancer, melanoma) and human cervical cancer specimens, accompanied by loss of heterozygosity at the X-linked Cosmc locus.\",\n      \"method\": \"Sequencing of Cosmc gene in cancer cell lines and tumor specimens, LOH analysis, correlation with antigen expression by immunostaining\",\n      \"journal\": \"Cancer research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — direct sequencing of mutations correlated with antigen expression across multiple cancer types and specimens, replicated in multiple cell lines\",\n      \"pmids\": [\"18339842\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"The lumenal domain of recombinant Cosmc directly interacts specifically with denatured (non-native) T-synthase in vitro, forming a stable complex and promoting partial refolding and restoration of T-synthase activity in an ATP-independent manner. A Tn-syndrome-associated mutant Cosmc has reduced chaperone function. The reactivated T-synthase remains noncovalently bound to Cosmc, and dissociation is promoted by client-driven competition with additional non-native T-synthase.\",\n      \"method\": \"In vitro refolding assay with recombinant proteins, solid-support binding assay, enzyme activity measurement, mutant Cosmc comparison\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — in vitro reconstitution with recombinant proteins, mutagenesis of disease-associated variant, multiple orthogonal assays\",\n      \"pmids\": [\"19923218\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Ablation of the X-linked Cosmc gene in mice causes embryonic lethality and widespread Tn antigen expression. Loss of Cosmc is specifically associated with loss of T-synthase protein but not other glycosylation enzymes, demonstrating that Cosmc is specifically required for T-synthase in vivo. Genetically mosaic mice with Cosmc deletion showed abnormalities correlated with Tn antigen expression.\",\n      \"method\": \"Conditional/germline gene knockout in mice, immunostaining for Tn antigen, enzyme activity assays, Western blot for glycosylation enzymes\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic ablation in mice with specific molecular phenotype, demonstrates in vivo specificity for T-synthase among glycosylation enzymes\",\n      \"pmids\": [\"20439703\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"The 18-amino acid transmembrane domain (TMD) of Cosmc is essential for ER localization and confers ER retention to chimeric proteins. A single Cys residue within the TMD is required for disulfide-bonded dimerization of Cosmc and ER retention; mutation of this Cys prevents dimer formation and eliminates ER retention.\",\n      \"method\": \"Chimeric protein construction with transferrin receptor, site-directed mutagenesis of Cys in TMD, immunofluorescence localization, biochemical analysis of dimer formation\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Moderate — mutagenesis combined with chimeric protein approach and localization, identifies specific ER-retention motif within TMD\",\n      \"pmids\": [\"21262965\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Cosmc mediates co-translational activation of C1GalT (T-synthase). Recombinant Cosmc must be present during translation of C1GalT to be effective; addition of Cosmc after translation does not restore activity, indicating Cosmc acts co-translationally to prevent unfavorable aggregation.\",\n      \"method\": \"Wheat germ cell-free translation system, simultaneous vs. post-translational addition of recombinant Cosmc, enzyme activity assay\",\n      \"journal\": \"FEBS letters\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Weak — cell-free translation reconstitution is Tier 1 but single lab, single study\",\n      \"pmids\": [\"21496458\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Cosmc binds specifically to denatured (non-native) T-synthase but not to the active dimeric form. Dissociation of T-synthase from the Cosmc complex is promoted by client-driven interaction with additional free non-native or native T-synthase molecules, defining a novel client-driven chaperone cycle.\",\n      \"method\": \"In vitro binding assays with recombinant lumenal domain of Cosmc on solid support, enzyme reactivation assays, competition experiments with free T-synthase forms\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro reconstitution with recombinant proteins, multiple conditions tested, defines mechanism of complex dissociation\",\n      \"pmids\": [\"22416136\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Epigenetic silencing of Cosmc through hypermethylation of its promoter CpG islands leads to loss of Cosmc transcripts in Tn4 B cells, resulting in absence of T-synthase activity and Tn antigen expression. Treatment with the demethylating agent 5-aza-2'-deoxycytidine restores Cosmc transcripts, T-synthase activity, and reduces Tn antigen expression.\",\n      \"method\": \"Bisulfite sequencing of Cosmc promoter, 5-aza-2'-deoxycytidine treatment, RT-PCR for Cosmc transcripts, T-synthase activity assay, flow cytometry for Tn antigen\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — bisulfite sequencing plus pharmacological rescue with two orthogonal readouts (transcript and enzyme activity), mechanistic link established\",\n      \"pmids\": [\"23035125\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Immunocytochemical analysis established that C1GalT (T-synthase) localizes to the Golgi apparatus while Cosmc localizes to the endoplasmic reticulum in human colon cancer cells. In Cosmc-mutant LSC cells, C1GalT protein is absent; proteasome inhibition with lactacystin causes accumulation of C1GalT but not in the Golgi. Overexpression of Cosmc directs C1GalT to the Golgi and restores core 1 synthase activity, demonstrating Cosmc controls the intracellular dynamics and proper Golgi targeting of C1GalT.\",\n      \"method\": \"Monoclonal antibody-based immunocytochemistry, proteasome inhibitor (lactacystin) treatment, Cosmc overexpression, co-localization with organelle markers\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct imaging with specific antibodies, functional rescue by overexpression, proteasome inhibitor validation, mechanistically defines chaperone-dependent Golgi trafficking\",\n      \"pmids\": [\"18061573\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"A cryptic linear, relatively hydrophobic peptide in the N-terminal stem region of T-synthase (termed CBRT, Cosmc binding region within T-synthase) is essential for binding to Cosmc. A synthetic CBRT peptide directly interacts with Cosmc and inhibits Cosmc-assisted in vitro refolding of T-synthase. Mutations within CBRT diminish T-synthase binding to Cosmc and result in formation of inactive T-synthase. Insertion of the T-synthase stem region into β4GalT1 confers Cosmc binding onto this chimera.\",\n      \"method\": \"Deletion mutagenesis, synthetic peptide binding assay, in vitro refolding inhibition assay, domain swap chimeric protein experiment, T-synthase activity assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — multiple orthogonal methods including mutagenesis, synthetic peptide binding, and domain swap chimera in a single study\",\n      \"pmids\": [\"24616093\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"The Cosmc core promoter, located within a CpG island (cCpG-II), contains two binding sites for Krüppel-like transcription factors (SP1/SP3), which drive basal ubiquitous transcription of Cosmc. Methylome analysis confirmed hypermethylation of the Cosmc core promoter in Tn4 B cells with silenced Cosmc, but not of the T-synthase promoter, demonstrating differential epigenetic regulation.\",\n      \"method\": \"Luciferase reporter assays, site-directed mutagenesis of SP1/SP3 binding sites, ChIP assays, mithramycin A treatment, methylome analysis/bisulfite sequencing\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Moderate — multiple orthogonal methods (reporter assay, mutagenesis, ChIP, pharmacological inhibition) identify specific transcription factor binding sites\",\n      \"pmids\": [\"26063800\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Limited proteolysis reveals Cosmc has a structured N-terminal domain (CosmcΔ256) with wild-type chaperone activity. The C-terminal domain is required for oligomerization (Cosmc forms monomeric, dimeric, trimeric, and tetrameric species) and divalent cation binding. The N-terminal domain mediates T-synthase binding. The disease-associated CosmcE152K mutant shows wild-type-like activity in vitro despite loss of function in vivo.\",\n      \"method\": \"Limited proteolysis, chemical crosslinking, blue native PAGE electrophoresis, thermal shift assays for metal binding, in vitro chaperone activity assays with truncation and point mutants\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Moderate — multiple biochemical methods characterize domain organization and oligomerization, mutagenesis separates functional domains\",\n      \"pmids\": [\"28665962\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Forced expression of Cosmc in HCT116 colon cancer cells increases T antigen expression and enhances cell growth, migration, and invasion via increased phosphorylation of FAK, ERK, and Akt. These effects are suppressed by MEK or PI3K inhibitors. Knockdown of Cosmc in SW480 cells decreases malignant behaviors and these signaling pathways, effects reversed by constitutively active Akt or MEK.\",\n      \"method\": \"Forced overexpression and siRNA knockdown, Western blot for phospho-FAK/ERK/Akt, MEK/PI3K inhibitors, cell growth/migration/invasion assays, in vivo SCID mouse tumor model\",\n      \"journal\": \"Molecular carcinogenesis\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 / Moderate — gain- and loss-of-function with pathway inhibitor rescue, in vivo validation, but mechanism linking O-glycosylation to kinase activation not directly established\",\n      \"pmids\": [\"23390052\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"COSMC overexpression in HUVECs increases T antigen expression, enhances cell growth, and increases phosphorylation of AKT and ERK. VEGFR2 carries O-glycans modulated by COSMC; COSMC overexpression delays VEGFR2 degradation while COSMC knockdown facilitates it. COSMC regulates VEGF-triggered phosphorylation of VEGFR2.\",\n      \"method\": \"Overexpression and siRNA knockdown, Western blot for O-glycans on VEGFR2, VEGFR2 degradation assay, VEGF stimulation assay, cell growth assays\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 / Moderate — identifies VEGFR2 as an O-glycoprotein substrate of Cosmc-dependent glycosylation with functional consequences for receptor stability and signaling\",\n      \"pmids\": [\"23424651\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Deletion of Cosmc in mouse intestinal epithelial cells (IEC-Cosmc-KO) causes marked reduction of microbiota diversity progressing from proximal to distal gut mucosa (but not lumen), emergence of a proinflammatory pathobiont, and distal gut pathology. Cosmc regulates host genes, bacterial ligands, and nutrient availability to control microbiota biogeography. Loss of one Cosmc allele in males causes compromised mucus layer and spontaneous microbe-dependent inflammation; female mosaic heterozygotes are protected due to lateral migration of normal mucin glycocalyx from WT cells.\",\n      \"method\": \"Conditional intestinal epithelial cell-specific Cosmc knockout in mice, microbiome sequencing, histology, experimental colitis models, comparison of hemizygous males vs. heterozygous females\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — conditional KO mouse model with defined cellular phenotype, microbiome analysis, multiple genetic configurations tested across sex\",\n      \"pmids\": [\"27930307\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"B cell-specific deletion of Cosmc causes developmental blocks in mouse B cells and failure to home to lymph nodes and non-lymphoid organs after transfer. Enzymatic desialylation of WT B cells also blocks migration into lymph nodes, indicating sialylated O-glycans are required for trafficking. Cosmc-deficient B cells show normal rolling and firm arrest on high endothelium venules (HEV) but impaired transendothelial migration and defective chemokine signaling responses.\",\n      \"method\": \"B cell-specific conditional Cosmc KO, adoptive transfer experiments, enzymatic desialylation of WT B cells, intravital imaging for rolling/arrest on HEV, chemokine signaling assays\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — conditional KO plus enzymatic rescue experiments, intravital imaging distinguishes rolling/arrest from transendothelial migration steps, multiple orthogonal approaches\",\n      \"pmids\": [\"32778659\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"Podocyte-specific Cosmc knockout mice develop profound albuminuria, foot process effacement, glomerular sclerosis, progressive renal failure, and impaired survival. Podoplanin O-glycoprotein expression is lost, and Tn antigen is most abundantly found on podocalyxin in KO cells. Cosmc-deficient podocytes forming foot processes interdigitating with those of normal podocytes (but not other KO cells) maintain function, suggesting a cell non-autonomous mechanism for O-glycoproteins in podocyte function.\",\n      \"method\": \"Podocyte-specific conditional Cosmc knockout, albuminuria measurement, electron microscopy for foot processes, glomerular transcriptome analysis, immunostaining for O-glycoproteins, analysis of mosaic heterozygous females\",\n      \"journal\": \"American journal of physiology. Renal physiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — conditional KO with detailed molecular and ultrastructural phenotyping, mosaic female analysis reveals cell non-autonomous mechanism\",\n      \"pmids\": [\"31904283\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"T cell-specific Cosmc conditional knockout (TCKO) mice show near-complete elimination of Cosmc-null T cells from spleen and lymph nodes. Cosmc-null thymocytes complete thymic maturation but fail to populate secondary lymphoid organs both natively and upon adoptive transfer to WT recipients, demonstrating that extended O-glycosylation is required for establishment and maintenance of the peripheral T cell population.\",\n      \"method\": \"Conditional T cell-specific Cosmc KO, flow cytometry for T cell populations, adoptive transfer experiments, thymocyte maturation analysis\",\n      \"journal\": \"Glycobiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — conditional KO with adoptive transfer dissects peripheral homing from thymic maturation, clean mechanistic separation\",\n      \"pmids\": [\"31317176\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"B cell-specific deletion of Cosmc causes spontaneous autoimmunity with elevated self-reactive IgM and IgG autoantibodies, enhanced basal B cell activation, increased spontaneous germinal center B cells, and multiple pathological phenotypes. Mechanistically, loss of Cosmc-dependent core 1 O-glycans confers enhanced B cell receptor (BCR) signaling through diminished BCR internalization.\",\n      \"method\": \"B cell-conditional Cosmc KO mice, autoantibody profiling, BCR signaling assays, BCR internalization assays, germinal center analysis by flow cytometry\",\n      \"journal\": \"Science advances\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — conditional KO with defined mechanistic readout (BCR internalization) linking O-glycosylation to immune checkpoint function\",\n      \"pmids\": [\"34613773\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"A germline hemizygous variant in C1GALT1C1 (c.59C>A, p.Ala20Asp) within the transmembrane domain of Cosmc results in dramatically reduced Cosmc protein expression (though the A20D-Cosmc protein retains function when expressed). This causes large reduction of T-synthase protein and activity in a cell/tissue-specific manner, leading to Tn-antigen expression on multiple glycoproteins, elevated galactose-deficient IgA1, and multisystem disease. Transient transfection of patient cells with WT C1GALT1C1 partially rescued T-synthase and glycosylation defect.\",\n      \"method\": \"Patient genetic analysis, Cosmc and T-synthase protein expression by Western blot, T-synthase activity assay, O-glycan profiling, transient transfection rescue experiment\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Moderate — human patient variant studied with functional assays, transfection rescue, and glycan profiling; demonstrates TMD mutation causes expression defect rather than activity defect\",\n      \"pmids\": [\"37216524\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"SLC35A2 (UDP-galactose transporter) associates with Cosmc as well as with C1GalT1 (T-synthase). In SLC35A2-deficient cells, protein levels of both C1GalT1 and Cosmc are decreased and their Golgi localization is less pronounced, suggesting NSTs contribute to stabilization and targeting of Cosmc and its client.\",\n      \"method\": \"Co-immunoprecipitation, Western blot in SLC35A2 KO cells, immunofluorescence localization\",\n      \"journal\": \"Biochimica et biophysica acta. Molecular cell research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Weak — co-IP demonstrates association but indirect evidence for functional consequence; single lab study\",\n      \"pmids\": [\"36933771\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"COSMC knockdown in pancreatic cancer cell lines via lentiviral shRNA reduces proliferation, increases migration, and decreases apoptosis. Nucleolin is identified as a novel O-GalNAc-modified protein in COSMC-deficient PDAC cell lines.\",\n      \"method\": \"Lentiviral shRNA knockdown, cell viability/migration/apoptosis assays, lectin-based glycoprotein enrichment with mass spectrometry, Western/Far-Western blot\",\n      \"journal\": \"Molecular cancer\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 / Moderate — KD with multiple phenotypic readouts and MS identification of substrate, but pathway from aberrant glycosylation to phenotype not fully resolved\",\n      \"pmids\": [\"26021314\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"Cosmc disruption via CRISPR/Cas9 in breast cancer cells (MCF7, T47D) suppresses cell growth in vitro and in vivo. Mechanistically, Cosmc deficiency impairs protein expression of CD44 and the associated MAPK signaling pathway; reconstitution of CD44 substantially reverses these alterations, demonstrating that CD44 requires normal O-glycosylation for proper expression and signaling.\",\n      \"method\": \"CRISPR/Cas9 Cosmc deletion, RTCA proliferation assay, colony formation, in vivo xenograft, Western blot for CD44 and MAPK pathway, CD44 reconstitution rescue\",\n      \"journal\": \"Cancer management and research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — CRISPR KO with rescue experiment identifies CD44 as mechanistic link, in vitro and in vivo validation\",\n      \"pmids\": [\"32158257\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"TNF-α downregulates COSMC mRNA and protein expression and induces hypermethylation of CpG islands in the COSMC gene promoter, leading to elevated Tn antigen levels. This defines a cytokine-Cosmc-Tn signaling axis.\",\n      \"method\": \"Cytokine treatment of gingival fibroblasts, RT-PCR and Western blot for COSMC, methylation-specific PCR/bisulfite sequencing of COSMC promoter, Tn antigen immunostaining\",\n      \"journal\": \"Oncotarget\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 / Weak — single lab, single study linking TNF-α to COSMC promoter methylation, but mechanistically shows epigenetic regulation by inflammatory cytokine\",\n      \"pmids\": [\"27542280\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"Hepatocyte-specific deletion of Cosmc in mice abolishes extended O-glycans on liver glycoproteins and causes expression of Tn antigen on hepatocyte-derived membrane glycoproteins and serum glycoproteins. The LDL receptor (LDLR), an O-glycosylated hepatocyte glycoprotein, is reduced from ~145 kDa to ~120 kDa in the absence of Cosmc-dependent glycosylation, but LDLR expression, HMG-CoA reductase expression, and cholesterol metabolism are unaffected, indicating that core 1 O-glycans on LDLR are not required for its stability or function.\",\n      \"method\": \"Hepatocyte-specific conditional Cosmc KO mouse, Western blot for LDLR and HMG-CoA reductase, O-glycan profiling, Tn antigen detection in serum\",\n      \"journal\": \"Glycobiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — conditional KO with biochemical characterization, single study defining hepatic O-glycan substrate landscape\",\n      \"pmids\": [\"39216105\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"COSMC coding mutations in advanced Alzheimer's disease brain tissue result in significantly reduced T-synthase activity (3-fold lower than advanced AD without mutations), demonstrating that somatic COSMC mutations can impair T-synthase function in brain tissue.\",\n      \"method\": \"Sequencing of COSMC in brain tissue, Q-RT-PCR, Western blotting, T-synthase activity assay\",\n      \"journal\": \"Alzheimer's & dementia (New York, N. Y.)\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — direct T-synthase activity assay in patient tissue correlating with COSMC mutations, but single study without mechanistic follow-up\",\n      \"pmids\": [\"32607408\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"C1GALT1C1/Cosmc encodes an X-linked, ER-resident type II transmembrane molecular chaperone that is the sole dedicated chaperone for T-synthase (core 1 β3-galactosyltransferase/C1GALT1): Cosmc binds co-translationally to a specific hydrophobic recognition motif (CBRT) in the N-terminal stem of newly synthesized T-synthase, prevents its aggregation and ubiquitin-proteasome-mediated degradation, promotes ATP-independent refolding, and directs T-synthase to the Golgi apparatus, where T-synthase catalyzes the addition of galactose to the Tn antigen to generate the core 1 O-glycan (T antigen) precursor for all extended mucin-type O-glycans; loss of Cosmc function—through somatic mutation, germline mutation, promoter hypermethylation (driven by SP1/SP3 sites), or cytokine/epigenetic suppression—abolishes T-synthase activity and causes global expression of the Tn antigen, with consequences ranging from embryonic lethality and autoimmunity to cancer progression and organ-specific pathologies including IgA nephropathy and hemolytic uremic syndrome.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"C1GALT1C1 (Cosmc) is an endoplasmic reticulum-resident molecular chaperone dedicated to folding and activating T-synthase (core 1 β3-galactosyltransferase/C1GALT1), the enzyme that builds the core 1 O-glycan (T antigen) precursor for all extended mucin-type O-glycans [#0, #2]. Cosmc binds a cryptic hydrophobic recognition motif (CBRT) in the N-terminal stem of non-native T-synthase, prevents its aggregation and ubiquitin-proteasome-mediated degradation, and promotes ATP-independent refolding, with reactivation operating through a client-driven dissociation cycle [#4, #8, #11]; in the absence of Cosmc, T-synthase fails to reach the Golgi and is degraded [#0, #10]. Its structured N-terminal domain mediates client binding while the C-terminal domain governs oligomerization and divalent-cation binding, and a transmembrane Cys-dependent disulfide dimer enforces ER retention [#6, #13]. Loss of Cosmc function—via somatic mutation with loss of heterozygosity, promoter CpG hypermethylation, or transcriptional silencing—abolishes T-synthase activity and produces global Tn/sialyl-Tn antigen expression in cancers and other pathologies [#3, #9, #12]. Basal transcription is driven by SP1/SP3 sites within the core promoter and is suppressed by inflammatory cytokine-induced promoter methylation [#12, #25]. In vivo, Cosmc is required embryonically and tissue-specifically: it controls intestinal mucus integrity and microbiota biogeography, B and T cell trafficking and BCR signaling/tolerance, and podocyte function, with several phenotypes arising cell non-autonomously [#5, #16, #17, #20, #18]. A germline transmembrane-domain variant (p.Ala20Asp) that reduces Cosmc protein expression causes multisystem disease with galactose-deficient IgA1, establishing a direct human disease link [#21].\",\n  \"teleology\": [\n    {\n      \"year\": 2002,\n      \"claim\": \"Established that core 1 O-glycosylation depends not only on a glycosyltransferase but on a dedicated partner, by showing T-synthase activity requires Cosmc and is otherwise lost to proteasomal degradation.\",\n      \"evidence\": \"Co-purification, cDNA rescue in Cosmc-mutant Jurkat cells, insect-cell co-expression, proteasome inhibitors\",\n      \"pmids\": [\"12464682\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism of T-synthase recognition not yet defined\", \"Subcellular site of action not resolved in this study\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Resolved where the chaperone and client act, showing Cosmc is ER-localized while T-synthase functions in the Golgi and requires Cosmc for proper Golgi targeting.\",\n      \"evidence\": \"Immunocytochemistry, lactacystin proteasome inhibition, Cosmc overexpression rescue in colon cancer cells\",\n      \"pmids\": [\"18061573\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Trafficking machinery handing off T-synthase from ER to Golgi unidentified\", \"How Cosmc is retained in ER not yet defined\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Defined the biochemical chaperone mechanism, demonstrating Cosmc directly binds T-synthase, prevents aggregation, and blocks its ubiquitin-mediated degradation, and clinically linked somatic Cosmc loss to tumor Tn/STn antigen expression.\",\n      \"evidence\": \"ATP-binding assays, ubiquitination assays, direct binding; plus Cosmc sequencing/LOH analysis in cancer cell lines and tumor specimens\",\n      \"pmids\": [\"18695044\", \"18339842\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Functional role of ATP binding not established\", \"Whether Tn expression drives or merely marks malignancy unresolved\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Reconstituted the chaperone reaction in vitro, proving Cosmc's lumenal domain binds denatured T-synthase and restores activity ATP-independently, and that a disease-associated mutant is functionally impaired.\",\n      \"evidence\": \"In vitro refolding and solid-support binding assays with recombinant proteins, mutant comparison\",\n      \"pmids\": [\"19923218\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis of binding not determined\", \"Energetics of refolding without ATP unexplained\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Demonstrated in vivo specificity and physiological essentiality, showing germline Cosmc ablation is embryonic lethal and selectively eliminates T-synthase among glycosylation enzymes.\",\n      \"evidence\": \"Germline/conditional mouse knockout, Tn immunostaining, enzyme activity and Western blots\",\n      \"pmids\": [\"20439703\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Cause of embryonic lethality not pinpointed\", \"Tissue-specific requirements not yet dissected\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Defined the timing and structural determinant of ER retention, showing Cosmc acts co-translationally and uses a TMD Cys-dependent disulfide dimer for ER retention.\",\n      \"evidence\": \"Wheat-germ cell-free translation timing experiments; chimeric proteins with TfR and TMD Cys mutagenesis\",\n      \"pmids\": [\"21496458\", \"21262965\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Co-translational mechanism shown in single cell-free study\", \"Whether dimerization is required for chaperone activity per se unclear\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Established the chaperone cycle, showing Cosmc selectively binds non-native (not active dimeric) T-synthase and is released through client-driven competition with additional T-synthase molecules.\",\n      \"evidence\": \"In vitro binding/reactivation and competition assays with recombinant Cosmc lumenal domain\",\n      \"pmids\": [\"22416136\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Stoichiometry of the in vivo cycle not measured\", \"Co-factors regulating release not identified\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Identified epigenetic silencing as a mechanism of functional loss, showing Cosmc promoter CpG hypermethylation abolishes transcripts and T-synthase activity, reversibly.\",\n      \"evidence\": \"Bisulfite sequencing, 5-aza-2'-deoxycytidine rescue, RT-PCR, activity and Tn assays in Tn4 B cells\",\n      \"pmids\": [\"23035125\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Trigger initiating hypermethylation not defined here\", \"Generality across cell types not established\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Mapped the client recognition element, identifying CBRT in the T-synthase N-terminal stem as the Cosmc-binding motif sufficient to confer Cosmc dependence on a heterologous transferase.\",\n      \"evidence\": \"Deletion/point mutagenesis, synthetic peptide binding, refolding inhibition, β4GalT1 domain-swap chimera\",\n      \"pmids\": [\"24616093\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Atomic-resolution structure of the Cosmc-CBRT interface lacking\", \"Why CBRT is cryptic in native enzyme not explained\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Defined transcriptional control of Cosmc, identifying SP1/SP3 sites in the core promoter driving basal expression and confirming selective promoter hypermethylation in silenced cells.\",\n      \"evidence\": \"Luciferase reporters, SP1/SP3 site mutagenesis, ChIP, mithramycin A, methylome analysis\",\n      \"pmids\": [\"26063800\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Inducible/tissue-specific regulators beyond SP1/SP3 unknown\", \"Link between methylation and TF occupancy not directly shown\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Delineated Cosmc domain architecture, separating an N-terminal chaperone domain from a C-terminal oligomerization/metal-binding domain and revealing a disease mutant active in vitro yet defective in vivo.\",\n      \"evidence\": \"Limited proteolysis, crosslinking, blue native PAGE, thermal shift, truncation/point-mutant chaperone assays\",\n      \"pmids\": [\"28665962\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Functional role of oligomerization and metal binding unresolved\", \"Why E152K fails in vivo despite in vitro activity unexplained\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Connected Cosmc to human Mendelian disease, showing a TMD variant (A20D) lowers Cosmc protein levels causing T-synthase loss, Tn antigen, galactose-deficient IgA1, and multisystem pathology.\",\n      \"evidence\": \"Patient genetics, Cosmc/T-synthase Western and activity assays, O-glycan profiling, transfection rescue\",\n      \"pmids\": [\"37216524\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism by which TMD variant lowers protein expression not detailed\", \"Tissue specificity of the defect incompletely explained\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Implicated the UDP-galactose transporter in Cosmc/T-synthase stability, showing SLC35A2 associates with both and that its loss reduces their levels and Golgi localization.\",\n      \"evidence\": \"Co-immunoprecipitation, Western blot in SLC35A2 KO cells, immunofluorescence\",\n      \"pmids\": [\"36933771\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Co-IP without reciprocal validation of direct binding\", \"Causal mechanism linking transporter loss to chaperone destabilization untested\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Linked Cosmc-dependent O-glycosylation to immune homeostasis across tissues, showing it is required for B and T cell peripheral establishment/trafficking, BCR signaling restraint, intestinal mucus/microbiota, and podocyte function, often cell non-autonomously.\",\n      \"evidence\": \"Lineage-specific conditional knockouts (B cell, T cell, intestinal epithelium, podocyte) with adoptive transfer, intravital imaging, microbiome sequencing, mosaic-female analysis\",\n      \"pmids\": [\"27930307\", \"32778659\", \"31317176\", \"34613773\", \"31904283\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Specific glycoprotein effectors in each tissue incompletely defined\", \"Molecular basis of cell non-autonomous rescue not fully resolved\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Began cataloguing tissue O-glycoprotein substrate landscapes and disease associations, identifying VEGFR2, CD44, nucleolin, podocalyxin/podoplanin, and LDLR as Cosmc-dependent glycoproteins with context-specific functional consequences.\",\n      \"evidence\": \"Conditional/CRISPR/shRNA Cosmc loss in endothelial, breast, pancreatic, podocyte, and hepatocyte systems with glycoprotein profiling and rescue\",\n      \"pmids\": [\"23424651\", \"32158257\", \"26021314\", \"31904283\", \"39216105\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct mechanistic link from altered O-glycan to each phenotype not fully established\", \"Several substrate findings from single labs without reciprocal validation\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How somatic and cytokine-driven Cosmc loss mechanistically contributes to specific disease pathologies, and the atomic structure of the Cosmc–T-synthase complex, remain open.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No high-resolution structure of Cosmc or the chaperone-client complex\", \"Causal chain from Tn antigen exposure to organ pathology incompletely defined\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0044183\", \"supporting_discovery_ids\": [0, 2, 4, 8]},\n      {\"term_id\": \"GO:0140096\", \"supporting_discovery_ids\": [2, 4, 11]},\n      {\"term_id\": \"GO:0140657\", \"supporting_discovery_ids\": [2]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005783\", \"supporting_discovery_ids\": [2, 6, 10]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-392499\", \"supporting_discovery_ids\": [0, 2, 4]},\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [17, 19, 20]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\"C1GALT1\", \"SLC35A2\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":7,"faith_total":7,"faith_pct":100.0}}